Literature DB >> 10596338

[Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome].

E Chiner1, J M Arriero, J Signes-Costa, J Marco, I Fuentes.   

Abstract

A Spanish version of the Epworth Sleepiness Scale (ESS-Sp) was developed by translation, back-translation, formal discussion, and a meeting of researchers with a group of patients with sleep apnea syndrome (SAS). The translated questionnaire was then tested in 345 patients, 275 with SAS at various levels of severity and 70 without SAS. Significant differences existed between the two groups as to age (53 +/- 11 years versus 47 +/- 13, p < 0.001) and BMI (32 +/- 5 versus 29.5 +/- 5, p < 0.001). Patients with SAS had significantly higher scores (14 +/- 5) than did those without SAS (10 +/- 5) (p < 0.001). Reproducibility was tested in 146 patients (113 SAS and 33 non-SAS), with no significant differences found among patients with SAS (14.9 +/- 5 versus 14.2 +/- 5, p = n.s.); significant differences in BMI were found, however, among the 33 non-SAS patients (12 +/- 5 versus 10 +/- 5, p < 0.01). Total scores and individual item scores were related in both groups. Likewise, each item was related to total score in patients with SAS. Sensitivity to post-treatment changes was assessed in 77 SAS patients, with initial scores of 16 +/- 4 seen to decrease to 4 +/- 3 after continuous positive airway pressure. ESS-Sp scores over 10 were recorded for 85% of patients with SAS: 78% of those with mild SAS, 85% of those with moderate disease and 92% of those whose SAS was severe. Significant inter-group differences were found upon applying a test of variance (p < 0.001). Differences continued to be detected when multiple correlations were looked for, with differences increasing with severity. SAS patients with ESS-Sp level one scores (< 10) had lower apnea-hypopnea indices (AHI) (35 +/- 18 versus 42 +/- 20, p < 0.05), lower desaturation levels (21 +/- 21 versus 34 +/- 28, p < 0.01) and higher minimum saturation (80 +/- 10 versus 75 +/- 12, p < 0.05), with no differences in age or BMI. A significant correlation was found between ESS-Sp score and respiratory variables recorded during polysomnography: AHI, r = 0.23 (p < 0.001); percent time in apnea-hypopnea, r = 0.18 (p < 0.01); desaturation index, r = 0.27 (p < 0.01) and minimum saturation (r = -0.14, p < 0.05). We conclude that the Spanish version of the ESS is equivalent to the original, is reproducible in patients with SAS, sensitive to post-treatment changes and seems to discriminate level of severity, showing correlation with polysomnograph variables.

Entities:  

Mesh:

Year:  1999        PMID: 10596338     DOI: 10.1016/s0300-2896(15)30037-5

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  59 in total

1.  Validation and modification of the Epworth Sleepiness Scale in Peruvian population.

Authors:  Edmundo Rosales-Mayor; Jorge Rey de Castro; Leandro Huayanay; Kenny Zagaceta
Journal:  Sleep Breath       Date:  2011-01-30       Impact factor: 2.816

Review 2.  A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.

Authors:  Emily Beth Devine; Zafar Hakim; Jesse Green
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Utility of the STOP-BANG components to identify sleep apnea using home respiratory polygraphy.

Authors:  Eduardo Borsini; Glenda Ernst; Alejandro Salvado; Martín Bosio; Julio Chertcoff; Facundo Nogueira; Carlos Nigro
Journal:  Sleep Breath       Date:  2015-04-24       Impact factor: 2.816

4.  Development and validation of a questionnaire to identify patients with sleep apnea in Mexican population: Mexican questionnaire to identify sleep apnea.

Authors:  Zaira Romero-López; María Dolores Ochoa-Vázquez; José Antonio Mata-Marín; Luis Gerardo Ochoa-Jiménez; Favio Gerardo Rico-Méndez
Journal:  Sleep Breath       Date:  2010-02-23       Impact factor: 2.816

5.  Ethnic differences in the prevalence and predictors of restless legs syndrome between Hispanics of Mexican descent and non-Hispanic Whites in San Diego county: a population-based study.

Authors:  Kittisak Sawanyawisuth; Lawrence A Palinkas; Sonia Ancoli-Israel; Joel E Dimsdale; José S Loredo
Journal:  J Clin Sleep Med       Date:  2013-01-15       Impact factor: 4.062

6.  Effect of CPAP therapy on job productivity and psychosocial occupational health in patients with moderate to severe sleep apnea.

Authors:  Bernabé Jurádo-Gámez; Ottavia Guglielmi; Francisco Gude-Sampedro; Gualberto Buela-Casal
Journal:  Sleep Breath       Date:  2015-04-01       Impact factor: 2.816

7.  Association of adverse perinatal outcomes with screening measures of obstructive sleep apnea.

Authors:  K M Antony; A Agrawal; M E Arndt; A M Murphy; P M Alapat; K K Guntupalli; K M Aagaard
Journal:  J Perinatol       Date:  2014-03-06       Impact factor: 2.521

8.  Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings.

Authors:  Sandra Giménez; Laura Videla; Sergio Romero; Bessy Benejam; Susana Clos; Susana Fernández; Maribel Martínez; Maria Carmona-Iragui; Rosa M Antonijoan; Mercedes Mayos; Ana Fortuna; Patricia Peñacoba; Vicente Plaza; Ricardo S Osorio; Ram A Sharma; Ignasi Bardés; Anne-Sophie Rebillat; Alberto Lleó; Rafael Blesa; Sebastian Videla; Juan Fortea
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

9.  Agreement between 95th percentile pressure based on a 7-night auto-adjusting positive airway pressure trial vs. equation-based predictions in sleep apnea.

Authors:  Luis Torre-Bouscoulet; Armando Castorena-Maldonado; Elodia López-Escárcega; Juan Carlos Vázquez-García; Rogelio Pérez-Padilla
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

10.  Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment.

Authors:  Raquel Català; Anna Cabré; Salvador Hernández-Flix; Raimón Ferré; Sandra Sangenís; Núria Plana; Anna Texidó; Lluís Masana
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.